Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: Comparison to adult rats

Journal of Neural Transmission

Volumn 117, Issue 5, 2010, Pages 573-583

  Der Ghazarian, Taleen ^b   Charntikov, Sergios ^a   Varela, Fausto A ^b   Crawford, Cynthia A ^b   McDougall, Sanders A ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Aripiprazole; Autoreceptors; DOPA accumulation; Dorsal striatum; Haloperidol; Ontogeny

Indexed keywords

ARIPIPRAZOLE; DOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; LEVODOPA; QUINPIROLE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; FEMALE; MALE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; AUTORECEPTORS; BRAIN CHEMISTRY; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HALOPERIDOL; MALE; PIPERAZINES; QUINOLONES; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2;

EID: 77952242564     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0396-5     Document Type: Article

References (75)

1. SL Andersen 2003 Trajectories of brain development: point of vulnerability or window of opportunity Neurosci Biobehav Rev 27 3 18 10.1016/S0149-7634(03)00005-8 12732219 (Pubitemid 36535387)
2. SL Andersen 2005 Stimulants and the developing brain Trends Pharmacol Sci 26 237 243 10.1016/j.tips.2005.03.009 1:CAS:528:DC%2BD2MXjslKhsL4%3D 15860370 (Pubitemid 40603071)
3. RJ Baldessarini ER Marsh D Huston-Lyons 1994 Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain Biochem Pharmacol 47 1917 1919 10.1016/0006-2952(94)90323-9 1:CAS:528:DyaK2cXksV2qtb4%3D 7911303 (Pubitemid 24172863)
4. MJ Bannon EB Bunney JR Zigun LR Skirboll RH Roth 1980 Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol Naunyn Schmiedebergs Arch Pharmacol 312 161 165 10.1007/BF00569725 1:CAS:528:DyaL3cXls1Wis7g%3D 6772975
5. DH Barzman MP DelBello RA Kowatch B Gernert DE Fleck S Pathak K Rappaport SV Delgado P Campbell SM Strakowski 2004 The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review J Child Adolesc Psychopharmacol 14 593 600 10.1089/cap.2004.14.593 15662152
6. J Biederman MA McDonnell J Wozniak T Spencer M Aleardi R Falzone E Mick 2005 Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review CNS Spectr 10 141 148 15685125
7. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D 942051
8. C Budman BJ Coffey R Shechter M Schrock N Wieland A Spirgel E Simon 2008 Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts J Child Adolesc Psychopharmacol 18 509 515 10.1089/cap.2007.061 18928415
9. KD Burris TF Molski C Xu E Ryan K Tottori T Kikuchi FD Yocca PB Molinoff 2002 Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors J Pharmacol Exp Ther 302 381 389 10.1124/jpet.102.033175 1:CAS:528:DC%2BD38Xlt1SnsLY%3D 12065741 (Pubitemid 34680462)
10. A Carlsson 1983 Dopamine receptor agonists: intrinsic activity vs. state of the receptor J Neural Transm 57 309 315 10.1007/BF01249001 1:CAS:528:DyaL2cXmt1eruw%3D%3D 6418858
11. D Centonze C Grande A Usiello P Gubellini E Erbs AB Martin A Pisani N Tognazzi G Bernardi R Moratalla E Borrelli P Calabresi 2003 Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons J Neurosci 23 6245 6254 1:CAS:528:DC%2BD3sXlvVCgs7w%3D 12867509
12. D Clark S Hjorth A Carlsson 1985 Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence J Neural Transm 62 1 52 10.1007/BF01260414 1:CAS:528:DyaL2MXltlGhsbo%3D 3894582 (Pubitemid 15072762)
13. D Clark S Hjorth A Carlsson 1985 Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations J Neural Transm 62 171 207 10.1007/BF01252236 1:CAS:528:DyaL2MXlvVyqsbo%3D 2863323 (Pubitemid 15067983)
14. D Clark RS Salah MP Galloway 1991 Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine Synapse 8 169 176 10.1002/syn.890080304 1:CAS:528:DyaK3MXlslCntb8%3D 1948667
15. S Coyle MG Ondrusek RB Mailman CD Kilts RA Mueller GR Breese 1981 Chronic treatment of neonatal rats with penfluridol results in permanent behavioral supersensitivity to apomorphine Fed Proc 40 238
16. B Drukarch JC Stoof 1990 D-2 dopamine autoreceptor selective drugs: do they really exist? Life Sci 47 361 376 10.1016/0024-3205(90)90293-Z 1:CAS:528:DyaK3cXlvVCjtrk%3D 1975636 (Pubitemid 20272057)
17. CM Farley SA Baella JJ Wacan CA Crawford SA McDougall 2006 Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: Longevity of agonistic effects Brain Res 1124 37 44 10.1016/j.brainres. 2006.09.068 1:CAS:528:DC%2BD28Xht1eksrjE 17070785 (Pubitemid 44779553)
18. MW Feltenstein CA Altar RE See 2007 Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse Biol Psychiatry 61 582 590 10.1016/j.biopsych.2006.04.010 1:CAS:528:DC%2BD2sXhvVynu74%3D 16806092 (Pubitemid 46328850)
19. RL Findling J Blumer R Kauffman J Batterson D Gilbert S Bramer R Marcus 2003 Aripiprazole in pediatric conduct disorder: a pilot study Eur Neuropsychopharmacol 13 Suppl 4 S335 10.1016/S0924-977X(03)92080-3
20. RL Findling A Robb M Nyilas RA Forbes N Jin S Ivanova R Marcus RD McQuade T Iwamoto WH Carson 2008 A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia Am J Psychiatry 165 1432 1441 10.1176/appi.ajp.2008.07061035 18765484
21. RL Findling R Kauffman FR Sallee DE Salazar V Sahasrabudhe G Kollia DM Kornhauser NN Vachharajani S Assuncao-Talbott S Mallikaarjun T Iwamoto RD McQuade DW Boulton J Blumer 2009 An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder J Child Adolesc Psychopharmacol 19 431 439 10.1089/cap.2008.0111 19702495
22. CS Fishburn C David S Carmon S Fuchs 1994 The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain FEBS Lett 339 63 66 10.1016/0014-5793(94)80385-4 1:CAS:528:DyaK2cXitlGqtrs%3D 8313980 (Pubitemid 24086652)
23. Friedhoff AJ, Miller JC (1983) Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems. In: Schlumpf M, Lichtensteiger W (eds) Drugs and hormones in brain development. Karger, Basel, pp 91-98
24. 35S]GTPγS binding in striatum of 6-hydroxydopamine-lesioned rats Brain Res 841 135 142 10.1016/S0006-8993(99)01812-0 1:CAS:528: DyaK1MXmslCgurw%3D 10546996 (Pubitemid 29441008)
25. 18F]fallypride PET study Am J Psychiatry 165 988 995 10.1176/appi.ajp.2008.07101574 18381901
26. CA Heidbreder MH Baumann 2001 Autoregulation of dopamine synthesis in subregions of the rat nucleus accumbens Eur J Pharmacol 411 107 113 10.1016/S0014-2999(00)00882-7 1:CAS:528:DC%2BD3MXht1Ggsr8%3D 11137864 (Pubitemid 32013117)
27. S Hjorth A Carlsson D Clark K Svensson H Wikstrom D Sanchez P Lindberg U Hacksell LE Arvidsson A Johansson JLG Nilsson 1983 Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP Psychopharmacology 81 89 99 10.1007/BF00428999 1:CAS:528:DyaL3sXls12ns7g%3D 6415751 (Pubitemid 13002844)
28. RR Holson B Pearce 1992 Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species Neurotoxicol Teratol 14 221 228 10.1016/0892-0362(92)90020-B 1:STN:280:DyaK38zkt1Wjuw%3D%3D 1635542
29. D Hoyer HWGM Boddeke 1993 Partial agonists, full agonists: dilemmas of definition Trends Pharmacol Sci 14 270 275 10.1016/0165-6147(93)90129-8 1:CAS:528:DyaK3sXlvFCrur8%3D 8105597
30. 2 receptors: homogenate binding and autoradiographic studies Neurochem Int 30 277 290 10.1016/S0197-0186(96)00093-9 1:CAS:528:DyaK2sXhtF2qtbo%3D 9041559 (Pubitemid 27055440)
31. SD Iñiguez AM Cortez CA Crawford SA McDougall 2008 Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats J Neural Transm 115 97 106 10.1007/s00702-007-0820-7 17994191
32. A Inoue S Miki M Seto T Kikuchi S Morita H Ueda Y Misu Y Nakata 1997 Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum Eur J Pharmacol 321 105 111 10.1016/S0014-2999(96) 00920-X 9083792 (Pubitemid 27096622)
33. 11C]DOPA: a stabilizing effect for dopaminergic neurotransmission? J Neurosci 29 13730 13734 10.1523/JNEUROSCI.4172-09.2009 1:CAS:528:DC%2BD1MXhsVSmt77I 19864585
34. H Kajiyama Y Nomura 1981 Alteration in dopaminergic and muscarinic cholinergic receptors after subchronic treatment with haloperidol in the developing rat brain J Pharmacobiodyn 4 85 90 1:CAS:528:DyaL3MXktlGnsb8%3D 7196947
35. 18F]fallypride Neuropsychopharmacology 33 3111 3125 10.1038/npp.2008.33 1:CAS:528:DC%2BD1cXhtlCktbvF 18418366
36. W Kehr 1984 Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism Eur J Pharmacol 97 111 119 10.1016/0014- 2999(84)90518-1 1:CAS:528:DyaL2cXps1Klsg%3D%3D 6421606
37. T Kikuchi K Tottori Y Uwahodo T Hirose T Miwa Y Oshiro S Morita 1995 7-(4-[4-(2, 3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3, 4-dihydro-2(1H)- quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity J Pharmacol Exp Ther 274 329 336 1:CAS:528: DyaK2MXntVWlt7c%3D 7616416
38. Kirk RE (1982) Experimental design, 2nd edn. Brooks/Cole, Pacific Grove, CA, pp 237-298
39. 2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol Dev Brain Res 45 95 101 10.1016/0165-3806(89) 90011-4 1:CAS:528:DyaL1MXovVCltA%3D%3D (Pubitemid 19019224)
40. J Lappalainen J Hietala M Koulu T Seppälä B Sjöholm E Syvälahti 1990 Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain J Pharmacol Exp Ther 252 845 852 1:CAS:528:DyaK3cXhslahsrk%3D 2179533 (Pubitemid 20101907)
41. Z Li J Ichikawa J Dai HY Meltzer 2004 Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain Eur J Pharmacol 493 75 83 10.1016/j.ejphar.2004.04.028 1:CAS:528:DC%2BD2cXkvV2htr0%3D 15189766 (Pubitemid 38746934)
42. N Lindgren A Usiello M Goiny J Haycock E Erbs P Greengard T Hökfelt E Borrelli G Fisone 2003 Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites Proc Natl Acad Sci USA 100 4305 4309 10.1073/pnas.0730708100 1:CAS:528:DC%2BD3sXivFWjsb8%3D 12651945 (Pubitemid 36418198)
43. O Magnusson B Mohringe CJ Fowler 1987 Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation J Neural Transm 69 163 177 10.1007/BF01244339 1:CAS:528:DyaL2sXmt12ktb4%3D 2957465
44. 1A receptor occupancy in patients with schizophrenia: a triple tracer PET study Am J Psychiatry 164 1411 1417 10.1176/appi.ajp.2007.06091479 17728427 (Pubitemid 47461142)
45. RN Marcus R Owen L Kamen G Manos RD McQuade WH Carson MG Aman 2009 A double-blind, randomized, placebo-controlled study of fixed-dose aripiprazole in children and adolescents with autistic disorder J Am Acad Child Adolesc Psychiatry 48 1110 1119 10.1097/CHI.0b013e3181b76658 19797985
46. G Masi A Cosenza S Millepiedi F Muratori C Pari F Salvadori 2009 Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study CNS Drugs 23 511 521 10.2165/00023210-200923060-00005 1:CAS:528:DC%2BD1MXosFGjsb0%3D 19480469
47. E Meller K Bohmaker Y Namba AJ Friedhoff M Goldstein 1987 Relationship between receptor occupancy and response at striatal autoreceptors Mol Pharmacol 31 592 598 1:CAS:528:DyaL2sXkslWgtLo%3D 2885734
48. TK Murphy MA Bengtson O Soto PJ Edge MW Sajid N Shapira M Yang 2005 Case series on the use of aripiprazole for Tourette syndrome Int J Neuropsychopharmacol 8 489 490 10.1017/S1461145705005365 1:CAS:528: DC%2BD2MXlsFams7g%3D 15857570 (Pubitemid 41002504)
49. TK Murphy PJ Mutch JM Reid PJ Edge EA Storch M Bengtson M Yang 2009 Open label aripiprazole in the treatment of youth with tic disorders J Child Adolesc Psychopharmacol 19 441 447 10.1089/cap.2008.0149 19702496
50. S Nakai T Hirose Y Uwahodo T Imaoka H Okazaki T Miwa M Nakai S Yamada B Dunn KD Burris PB Molinoff K Tottori CA Altar T Kikuchi 2003 Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone Eur J Pharmacol 472 89 97 10.1016/S0014-2999(03)01857-0 1:CAS:528:DC%2BD3sXlsVams70%3D 12860477 (Pubitemid 36830995)
51. SP Onn AA Grace 1995 Repeated treatment with haloperidol and clozapine exerts differential effects on dye coupling between neurons in subregions of striatum and nucleus accumbens J Neurosci 15 7024 7036 1:CAS:528: DyaK2MXptlOnur4%3D 7472458
52. C Orsini GF Koob L Pulvirenti 2001 Dopamine partial agonist reverses amphetamine withdrawal in rats Neuropsychopharmacology 25 789 792 10.1016/S0893-133X(01)00270-6 1:CAS:528:DC%2BD3MXnslCjtrw%3D 11682262 (Pubitemid 32995961)
53. Y Oshiro S Sato N Kurahashi T Tanaka T Kikuchi K Tottori Y Uwahodo T Nishi 1998 Novel antipsychotic agents with dopamine autoreceptor agonist properties: Synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]- 3, 4-dihydro-2(1H)-quinolinone derivatives J Med Chem 41 658 667 10.1021/jm940608g 1:CAS:528:DyaK1cXosFaqtw%3D%3D 9513593 (Pubitemid 28114874)
54. A Reches HR Wagner V Jackson-Lewis S Fahn 1985 Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade Brain Res 347 346 349 10.1016/0006-8993(85)90196-9 1:CAS:528:DyaL2MXmtVOntrw%3D 3933764 (Pubitemid 16213510)
55. H Rosengarten AJ Friedhoff 1979 Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats Science 203 1133 1135 10.1126/science.570724 1:CAS:528:DyaE1MXhvVSht7g%3D 570724
56. 2 receptor ontogeny Peptides 10 35 39 10.1016/0196-9781(89)90072-7 1:CAS:528:DyaL1MXitVKgtL4%3D 2568624 (Pubitemid 19108032)
57. B Scatton C Garret L Julou 1975 Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum Naunyn Schmiedebergs Arch Pharmacol 289 419 434 10.1007/BF00508415 1:CAS:528: DyaE2MXlslalurc%3D 240136
58. (High) receptors moderately elevated by bifeprunox and aripiprazole Synapse 62 902 908 10.1002/syn.20557 1:CAS:528:DC%2BD1cXhtlKiu7bJ 18792990
59. Spear LP (1979) The use of psychopharmacological procedures to analyse the ontogeny of learning and retention: issues and concerns. In: Spear NE, Campbell BA (eds) Ontogeny of learning and memory. Lawrence Erlbaum Associates, Hillsdale, NJ, pp 135-156
60. JM Stachnik C Nunn-Thompson 2007 Use of atypical antipsychotics in the treatment of autistic disorder Ann Pharmacother 41 626 634 10.1345/aph.1H527 1:CAS:528:DC%2BD2sXltlOnsrg%3D 17389666 (Pubitemid 46625485)
61. KA Stigler DJ Posey CJ McDougle 2004 Aripiprazole for maladaptive behavior in pervasive developmental disorders J Child Adolesc Psychopharmacol 14 455 463 10.1089/cap.2004.14.455 15650503 (Pubitemid 39473132)
62. KA Stigler JT Diener AE Kohn L Li CA Erickson DJ Posey CJ McDougle 2009 Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study J Child Adolesc Psychopharmacol 19 265 274 10.1089/cap.2008.093 19519261
63. G Stock P Kummer 1981 Long-term application of haloperidol: effects on dopamine and acetylcholine receptors Int Pharmacopsychiatry 16 144 153 1:CAS:528:DyaL38XnvFOktA%3D%3D 6797983
64. G Stock J Steinbrenner P Kummer 1980 Supersensitivity of dopamine-autoreceptors: the effect of gammabutyrolactone in long-term haloperidol treated rats J Neural Transm 47 145 151 10.1007/BF01670165 1:CAS:528:DyaL3cXktF2gtrw%3D 7373289
65. K Svensson A Ekman MF Piercey WE Hoffmann JT Lum A Carlsson 1991 Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study Naunyn Schmiedebergs Arch Pharmacol 344 263 274 10.1007/BF00182999 1:CAS:528:DyaK3MXmslSms7o%3D 1683686
66. K Svensson E Eriksson A Carlsson 1993 Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects Neuropharmacology 32 1037 1045 10.1016/0028-3908(93)90069-F 1:CAS:528:DyaK2cXksFOjug%3D%3D 7905192 (Pubitemid 23316511)
67. 2) receptor up-regulation in the rat Neurosci Lett 231 91 94 10.1016/S0304-3940(97)00527-2 1:CAS:528:DyaK2sXlslelsLk%3D 9291148 (Pubitemid 27386497)
68. E Tirelli G Laviola W Adriani 2003 Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents Neurosci Biobehav Rev 27 163 178 10.1016/S0149-7634(03)00018- 6 12732232 (Pubitemid 36535398)
69. S Tramontina CP Zeni CR Ketzer GF Pheula J Narvaez LA Rohde 2009 Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial J Clin Psychiatry 70 756 764 10.4088/JCP.08m04726 1:CAS:528:DC%2BD1MXhsFCltb7E 19389329
70. SM Vasconcelos VS Nascimento CR Nogueira CM Vieira FC Sousa MM Fonteles GS Viana 2003 Effects of haloperidol on rat behavior and density of dopaminergic D2-like receptors Behav Processes 63 45 52 10.1016/S0376-6357(03)00028-7 12763267 (Pubitemid 36577659)
71. 18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: a positron emission tomography study in healthy subjects Neuroimage 40 1222 1231 10.1016/j.neuroimage.2007.12.045 18262797
72. 2 receptor binding and dopamine turnover Life Sci 62 1161 1169 10.1016/S0024-3205(98)00042-3 1:CAS:528:DyaK1cXhsVKhsLg%3D 9519797 (Pubitemid 28153475)
73. 11C] raclopride Neuropsychopharmacology 27 248 259 10.1016/S0893-133X(02)00304-4 1:CAS:528:DC%2BD38XkvFyqt74%3D 12093598 (Pubitemid 34692591)
74. 2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats Brain Res 1073/1074 269 275 10.1016/j.brainres.2005.12.054
75. EP Zorrilla 1997 Multiparous species present problems (and possibilities) to developmentalists Dev Psychobiol 30 141 150 10.1002/(SICI)1098-2302(199703) 30:2<141::AID-DEV5>3.0.CO;2-Q 1:STN:280:DyaK2s3itF2hsA%3D%3D 9068968